Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 03/31/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 1.03B | 1.02B | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 1.03B | 1.02B | |
| Cost of Revenue | -- | -- | 720.74M | 711.29M | |
| Gross Profit | -- | -- | 308.45M | 303.87M | |
| SG&A Expenses | -- | -- | 257.70M | 254.57M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -237.60K | -1.18M | |
| Total Operating Expenses | -- | -- | 978.20M | 964.68M | |
| Operating Income | -- | -- | 50.99M | 50.48M | |
| Income Before Tax | -- | -- | 24.41M | 24.47M | |
| Income Tax Expenses | -- | -- | 10.93M | 9.75M | |
| Earnings from Continuing Operations | -- | -- | 13.48 | 14.73 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | 13.48M | 14.73M | |
| EBIT | -- | -- | 50.99M | 50.48M | |
| EBITDA | -- | -- | 109.77M | 106.64M | |
| EPS Basic | -- | -- | 0.03 | 0.04 | |
| Normalized Basic EPS | -- | -- | 0.04 | 0.04 | |
| EPS Diluted | -- | -- | 0.03 | 0.04 | |
| Normalized Diluted EPS | -- | -- | 0.04 | 0.04 | |
| Average Basic Shares Outstanding | -- | -- | 1.64B | 1.64B | |
| Average Diluted Shares Outstanding | -- | -- | 1.64B | 1.64B | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |